Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down After Analyst Downgrade
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) shares gapped down before the market opened on Friday after UBS Group lowered their price target on the stock from $8.00 to $2.50. The stock had previously closed at $2.40, but opened at $2.12. UBS Group currently has a neutral rating on the stock. Maravai LifeSciences […]
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) shares gapped down before the market opened on Friday after UBS Group lowered their price target on the stock from $8.00 to $2.50. The stock had previously closed at $2.40, but opened at $2.12. UBS Group currently has a neutral rating on the stock. Maravai LifeSciences […]
